USD 0.01
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 59 Thousand USD | -30.59% |
2022 | 85 Thousand USD | -61.36% |
2021 | 220 Thousand USD | 11.68% |
2020 | 197 Thousand USD | -73.77% |
2019 | 751 Thousand USD | 0.0% |
2013 | 2.64 Million USD | -4.55% |
2012 | 2.76 Million USD | -48.71% |
2011 | 5.39 Million USD | -16.81% |
2010 | 6.49 Million USD | -59.12% |
2009 | 15.87 Million USD | -7.2% |
2008 | 17.1 Million USD | 2.43% |
2007 | 16.7 Million USD | 0.61% |
2006 | 16.6 Million USD | 4.28% |
2005 | 15.91 Million USD | 8.22% |
2004 | 14.71 Million USD | -7.92% |
2003 | 15.97 Million USD | -50.91% |
2002 | 32.54 Million USD | -5.37% |
2001 | 34.39 Million USD | -6.22% |
2000 | 36.66 Million USD | 19.44% |
1999 | 30.7 Million USD | -43.15% |
1998 | 54 Million USD | -5.1% |
1997 | 56.9 Million USD | -10.25% |
1996 | 63.4 Million USD | 126.43% |
1995 | 28 Million USD | 143.48% |
1994 | 11.5 Million USD | -26.28% |
1993 | 15.6 Million USD | -17.89% |
1992 | 19 Million USD | 4.97% |
1991 | 18.1 Million USD | 201.67% |
1990 | 6 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 12 Thousand USD | 0.0% |
2023 Q2 | 28 Thousand USD | -9.68% |
2023 Q1 | 31 Thousand USD | 0.0% |
2023 Q3 | - USD | -100.0% |
2023 FY | 59 Thousand USD | -30.59% |
2022 FY | 85 Thousand USD | -61.36% |
2022 Q2 | 40 Thousand USD | 73.91% |
2022 Q1 | 23 Thousand USD | 0.0% |
2021 Q1 | 84 Thousand USD | 0.0% |
2021 FY | 220 Thousand USD | 11.68% |
2021 Q2 | 82 Thousand USD | -2.38% |
2020 FY | 197 Thousand USD | -73.77% |
2019 FY | 751 Thousand USD | 0.0% |
2018 Q2 | 1.14 Million USD | -11.1% |
2018 Q1 | 1.28 Million USD | 0.0% |
2018 Q3 | 894 Thousand USD | -21.92% |
2018 Q4 | 1.63 Million USD | 83.0% |
2017 Q3 | 6164.00 USD | 0.0% |
2016 Q3 | 739.00 USD | 0.0% |
2014 Q2 | 825 Thousand USD | 30.33% |
2014 Q1 | 633 Thousand USD | 0.0% |
2014 Q3 | 782 Thousand USD | -5.21% |
2013 Q3 | 649 Thousand USD | -4.98% |
2013 Q2 | 683 Thousand USD | 2.4% |
2013 Q1 | 667 Thousand USD | -0.45% |
2013 FY | 2.64 Million USD | -4.55% |
2012 Q2 | 571 Thousand USD | -25.75% |
2012 Q4 | 670 Thousand USD | 3.55% |
2012 FY | 2.76 Million USD | -48.71% |
2012 Q1 | 769 Thousand USD | 15.12% |
2012 Q3 | 647 Thousand USD | 13.31% |
2011 Q1 | 778 Thousand USD | -55.24% |
2011 FY | 5.39 Million USD | -16.81% |
2011 Q4 | 668 Thousand USD | -12.22% |
2011 Q3 | 761 Thousand USD | -3.79% |
2011 Q2 | 791 Thousand USD | 1.67% |
2010 FY | 6.49 Million USD | -59.12% |
2010 Q3 | 2.16 Million USD | 37.62% |
2010 Q2 | 1.57 Million USD | -8.72% |
2010 Q1 | 1.72 Million USD | 10.04% |
2010 Q4 | 1.73 Million USD | -19.61% |
2009 Q2 | 5.16 Million USD | 65.21% |
2009 Q4 | 1.56 Million USD | -4.28% |
2009 Q3 | 1.63 Million USD | -68.37% |
2009 Q1 | 3.12 Million USD | -16.57% |
2009 FY | 15.87 Million USD | -7.2% |
2008 Q3 | 3.7 Million USD | -11.82% |
2008 Q2 | 4.19 Million USD | -7.6% |
2008 Q1 | 4.54 Million USD | -32.13% |
2008 FY | 17.1 Million USD | 2.43% |
2008 Q4 | 3.74 Million USD | 1.3% |
2007 Q3 | 6.09 Million USD | 30.26% |
2007 Q2 | 4.67 Million USD | 9.96% |
2007 Q4 | 6.69 Million USD | 9.78% |
2007 FY | 16.7 Million USD | 0.61% |
2007 Q1 | 4.25 Million USD | 6.99% |
2006 Q3 | 3.79 Million USD | -20.36% |
2006 FY | 16.6 Million USD | 4.28% |
2006 Q1 | 3.79 Million USD | -5.13% |
2006 Q2 | 4.76 Million USD | 25.53% |
2006 Q4 | 3.97 Million USD | 4.91% |
2005 FY | 15.91 Million USD | 8.22% |
2005 Q1 | 3.74 Million USD | 8.05% |
2005 Q2 | 4.9 Million USD | 30.84% |
2005 Q4 | 3.99 Million USD | -1.31% |
2005 Q3 | 4.05 Million USD | -17.35% |
2004 FY | 14.71 Million USD | -7.92% |
2004 Q4 | 3.46 Million USD | -8.65% |
2004 Q3 | 3.79 Million USD | 50.32% |
2004 Q2 | 2.52 Million USD | -32.73% |
2004 Q1 | 3.75 Million USD | -5.54% |
2003 Q4 | 3.97 Million USD | -0.15% |
2003 Q2 | 3.53 Million USD | -9.1% |
2003 Q1 | 3.89 Million USD | -15.34% |
2003 FY | 15.97 Million USD | -50.91% |
2003 Q3 | 3.97 Million USD | 12.47% |
2002 Q1 | 7.98 Million USD | -9.19% |
2002 Q2 | 7.15 Million USD | -10.35% |
2002 Q3 | 6.8 Million USD | -4.95% |
2002 Q4 | 4.59 Million USD | -32.41% |
2002 FY | 32.54 Million USD | -5.37% |
2001 Q1 | 19.36 Million USD | 90.43% |
2001 Q3 | 8.6 Million USD | 366.45% |
2001 Q4 | 8.78 Million USD | 2.17% |
2001 FY | 34.39 Million USD | -6.22% |
2001 Q2 | -3.22 Million USD | -116.67% |
2000 Q1 | 8.34 Million USD | -5.14% |
2000 Q4 | 10.17 Million USD | 25.91% |
2000 FY | 36.66 Million USD | 19.44% |
2000 Q2 | 11.79 Million USD | 41.28% |
2000 Q3 | 8.07 Million USD | -31.52% |
1999 Q3 | 7.8 Million USD | 1.3% |
1999 FY | 30.7 Million USD | -43.15% |
1999 Q4 | 8.8 Million USD | 12.82% |
1999 Q1 | 7.9 Million USD | 2.6% |
1999 Q2 | 7.7 Million USD | -2.53% |
1998 Q2 | 8.7 Million USD | -50.0% |
1998 Q3 | 7.6 Million USD | -12.64% |
1998 Q4 | 7.7 Million USD | 1.32% |
1998 FY | 54 Million USD | -5.1% |
1998 Q1 | 17.4 Million USD | 5.45% |
1997 Q2 | 3.6 Million USD | -80.54% |
1997 FY | 56.9 Million USD | -10.25% |
1997 Q3 | 11.5 Million USD | 219.44% |
1997 Q1 | 18.5 Million USD | 10.78% |
1997 Q4 | 16.5 Million USD | 43.48% |
1996 FY | 63.4 Million USD | 126.43% |
1996 Q4 | 16.7 Million USD | -8.24% |
1996 Q3 | 18.2 Million USD | 0.55% |
1996 Q2 | 18.1 Million USD | 9.7% |
1996 Q1 | 16.5 Million USD | 194.64% |
1995 Q2 | 10 Million USD | 56.25% |
1995 FY | 28 Million USD | 143.48% |
1995 Q4 | 5.6 Million USD | -18.84% |
1995 Q3 | 6.9 Million USD | -31.0% |
1995 Q1 | 6.4 Million USD | 8.47% |
1994 Q2 | 3.9 Million USD | 34.48% |
1994 Q1 | 2.9 Million USD | 20.83% |
1994 FY | 11.5 Million USD | -26.28% |
1994 Q4 | 5.9 Million USD | 9.26% |
1994 Q3 | 5.4 Million USD | 38.46% |
1993 Q1 | 5.9 Million USD | 13.46% |
1993 FY | 15.6 Million USD | -17.89% |
1993 Q4 | 2.4 Million USD | 0.0% |
1993 Q3 | 2.4 Million USD | 580.0% |
1993 Q2 | -500 Thousand USD | -108.47% |
1992 Q1 | 4.6 Million USD | 0.0% |
1992 Q2 | 5.6 Million USD | 21.74% |
1992 Q3 | 5 Million USD | -10.71% |
1992 FY | 19 Million USD | 4.97% |
1992 Q4 | 5.2 Million USD | 4.0% |
1991 Q3 | 4.1 Million USD | 0.0% |
1991 Q1 | 4.6 Million USD | 0.0% |
1991 Q2 | 4.1 Million USD | -10.87% |
1991 FY | 18.1 Million USD | 201.67% |
1991 Q4 | 4.6 Million USD | 12.2% |
1990 FY | 6 Million USD | 0.0% |
1990 Q2 | -21.7 Million USD | 0.0% |
1990 Q4 | - USD | 0.0% |
1990 Q1 | - USD | 0.0% |
1990 Q3 | - USD | 100.0% |
1989 Q3 | - USD | 0.0% |
1989 Q4 | - USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
CVR Medical Corp. | - USD | -Infinity% |
BioElectronics Corporation | 740.67 Thousand USD | 92.034% |
IR-Med Inc. | 4.89 Million USD | 98.794% |
Polarean Imaging plc | 12.24 Million USD | 99.518% |
Medical Supply International USA, Inc. | 1.32 Million USD | 95.532% |
Avitar, Inc. | 3.56 Million USD | 98.347% |
AVITA Medical, Inc. | 80.77 Million USD | 99.927% |
Manhattan Scientifics, Inc. | 703 Thousand USD | 91.607% |
Össur hf. | 396.18 Million USD | 99.985% |
Zecotek Photonics Inc. | 3.46 Million USD | 98.296% |
QHSLab, Inc. | 961.65 Thousand USD | 93.865% |
Wellstar International, Inc. | 1.79 Million USD | 96.713% |
Össur hf. | 396.18 Million USD | 99.985% |
Bionovate Technologies Corp | - USD | -Infinity% |
EKF Diagnostics Holdings plc | 21.77 Million USD | 99.729% |
Escalon Medical Corp. | 5.25 Million USD | 98.876% |
Aurora Spine Corporation | 8.65 Million USD | 99.319% |
BrainsWay Ltd. | 28.01 Million USD | 99.789% |
Lattice Biologics Ltd. | - USD | -Infinity% |
NewCardio, Inc. | 9.56 Million USD | 99.383% |
Hamilton Thorne Ltd. | 33.57 Million USD | 99.824% |
Vivos Inc. | 2.78 Million USD | 97.883% |
MicroPort Scientific Corporation | 1.04 Billion USD | 99.994% |
Kelyniam Global, Inc. | 2.27 Million USD | 97.407% |
REMSleep Holdings, Inc. | 1.01 Million USD | 94.187% |
CYduct Diagnostics, Inc. | 435.5 Thousand USD | 86.452% |
Nanomix Corporation | 8.36 Million USD | 99.295% |
Theraclion SA | 7.43 Million USD | 99.207% |
Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
Wellness Center USA, Inc. | 1.29 Million USD | 95.443% |
Positron Corporation | 1 Million USD | 94.143% |
Rafina Innovations Inc. | - USD | -Infinity% |
Electromedical Technologies, Inc. | 3.11 Million USD | 98.103% |
Lombard Medical, Inc. | 30.29 Million USD | 99.805% |
ALR Technologies Inc. | 6.33 Million USD | 99.069% |
Stratec SE | 46.32 Million USD | 99.873% |
Vycor Medical, Inc. | 1.27 Million USD | 95.374% |
Heart Tronics, Inc. | 14.46 Million USD | 99.592% |
Nu-Med Plus, Inc. | 120.52 Thousand USD | 51.048% |
Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | 71.417% |
SANUWAVE Health, Inc. | 14.15 Million USD | 99.583% |
VMS Rehab Systems, Inc. | 63.63 USD | -92623.558% |
Guided Therapeutics, Inc. | 3.49 Million USD | 98.311% |
Ingen Technologies, Inc. | 1.88 Million USD | 96.865% |
Odyssey Group International, Inc. | -14.26 Million USD | 100.414% |
ECGI Holdings, Inc. | 407.48 Thousand USD | 85.521% |
Capital Group Holdings, Inc. | 634.68 Thousand USD | 90.704% |
ADM Tronics Unlimited, Inc. | 1.69 Million USD | 96.52% |
Urologix, Inc. | 10.09 Million USD | 99.415% |
Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | 95.33% |
Nexeon MedSystems Inc. | 5.94 Million USD | 99.008% |
SS Innovations International, Inc. | 21.38 Million USD | 99.724% |
Qualis Innovations, Inc. | 230.24 Thousand USD | 74.375% |
Smith & Nephew plc | 3.46 Billion USD | 99.998% |
NIOX Group Plc | 22.27 Million USD | 99.735% |
Fuse Medical, Inc. | 10.35 Million USD | 99.43% |
Broncus Holding Corporation | 38.15 Million USD | 99.845% |
Brain Scientific Inc. | 9.66 Million USD | 99.389% |
Pressure BioSciences, Inc. | 10.3 Million USD | 99.427% |
Health Logic Interactive Inc. | 60.69 Thousand USD | 2.797% |